JAMES L L TULLIS
CIK 1230641 · last filed 2026-06-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.34M
Companies
7
Total Filings
104
Lifetime Open-Market Net
-$8.42M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CR | Director | 6,449 | $226.34 | $1.46M | $0 | 8 | 2026-06-01 |
| CXT | Director | 9,960 | $54.56 | $543.4K | $0 | 9 | 2026-05-26 |
| ATEC | Director | 797,893 | $9.32 | $7.44M | -$7.83M | 20 | 2023-09-13 |
| XGN | Director | 25,885 | $4.45 | $115.2K | -$1.80M | 20 | 2022-06-21 |
| ECOR | Director | 129,277 | $6.09 | $787.3K | $1.59M | 5 | 2020-04-16 |
| INTERPHARM HOLDINGS INC (IPA) Delisted | 10%+ Owner | — | $2.07 | — | $0 | 1 | 2008-02-29 |
| VIACELL INC (VIAC) Delisted | Director | 1,753,221 | $29.58 | $51.86M | -$375.0K | 2 | 2007-01-29 |
Recent Filings · Page 2 of 11
104 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-11-27 | CXT | Gift (G) | −103 | $0 | EDGAR |
| 2023-11-20 | CXT | Gift (G) | −130 | $0 | EDGAR |
| 2023-09-13 | ATEC | Sell (S) | −105,000 | -$1.55M | EDGAR |
| 2023-09-11 | ATEC | Notice (144) | −35,000 | -$515.9K | EDGAR |
| 2023-09-07 | CXT | Gift (G) | −330 | $0 | EDGAR |
| 2023-06-21 | ATEC | Grant (A) | +9,908 | $0 | EDGAR |
| 2023-06-02 | CR | Gift (G) | −260 | $0 | EDGAR |
| 2023-05-18 | ATEC | Mixed | +201,705 | $23 | EDGAR |
| 2023-05-16 | ATEC | Mixed | +201,973 | $10 | EDGAR |
| 2023-04-26 | CR | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.